SOSV

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

Innatrix is an agricultural biotechnology company developing novel biological and chemical products based on patented protein evolution technology, to control untreatable crop diseases, pests, and weeds.

Innatrix is an agricultural biotechnology company developing novel biological and chemical products based on patented protein evolution technology, to control untreatable crop diseases, pests, and weeds.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

VemiCo is a biotechnology company.

Ardra is a startup based on technology developed at the University of Toronto. Their technology uses model-guided metabolic engineering and synthetic biology to develop biocatalysts for the production of specialty chemicals from renewable resources. Their current target is the cosmetics industry, which uses $2.6 billion worth of petroleum chemicals in a variety of products.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

Developing technology to fight mosquitoes with mosquitoes.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.

Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

Nordetect is a biochemical analytics company based in Copenhagen, Denmark, that specializes in the development of Lab-on-a-chip devices for environmental analysis, particularly in the field of agriculture. The company has created a microfluidic chip that accurately detects and quantifies essential macronutrients, including nitrogen, phosphorus, and potassium, in soil. This technology enables reliable and affordable nutrient testing, allowing agronomists and farm-service providers to offer farmers precise insights into their soil's nutritional content. By analyzing the effectiveness of chemical and organic fertilizers, Nordetect's solutions help optimize crop performance and provide recommendations for altering agricultural practices. Founded in 2016, Nordetect aims to enhance the sustainability and efficiency of farming through innovative biochemical analysis.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more. Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product.

Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more. Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product.

Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Developing technology to fight mosquitoes with mosquitoes.

Developing hardware for manufacturing next-generation medicines.

Developing hardware for manufacturing next-generation medicines.

Nordetect is a biochemical analytics company based in Copenhagen, Denmark, that specializes in the development of Lab-on-a-chip devices for environmental analysis, particularly in the field of agriculture. The company has created a microfluidic chip that accurately detects and quantifies essential macronutrients, including nitrogen, phosphorus, and potassium, in soil. This technology enables reliable and affordable nutrient testing, allowing agronomists and farm-service providers to offer farmers precise insights into their soil's nutritional content. By analyzing the effectiveness of chemical and organic fertilizers, Nordetect's solutions help optimize crop performance and provide recommendations for altering agricultural practices. Founded in 2016, Nordetect aims to enhance the sustainability and efficiency of farming through innovative biochemical analysis.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Nordetect is a biochemical analytics company based in Copenhagen, Denmark, that specializes in the development of Lab-on-a-chip devices for environmental analysis, particularly in the field of agriculture. The company has created a microfluidic chip that accurately detects and quantifies essential macronutrients, including nitrogen, phosphorus, and potassium, in soil. This technology enables reliable and affordable nutrient testing, allowing agronomists and farm-service providers to offer farmers precise insights into their soil's nutritional content. By analyzing the effectiveness of chemical and organic fertilizers, Nordetect's solutions help optimize crop performance and provide recommendations for altering agricultural practices. Founded in 2016, Nordetect aims to enhance the sustainability and efficiency of farming through innovative biochemical analysis.

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the most lethal diseases. It combines low-residual, ML-based computational chemistry and mathematically guaranteed, superlinear search algorithms to find optimized drug candidates. The company's platform, COPPER, leverages its proprietary AI and state-of-the-art physical models to explore an unprecedentedly large chemical space, allowing them to discover new therapeutics to targets previously believed undruggable.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

VemiCo is a biotechnology company.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

CorNatural develops bio-based sustainable products to offer a range of natural products. The company aims to upcycle waste streams into value-added products, using pioneering synthetic biology and genetic engineering techniques. CorNatural was founded in 2019 and is headquartered in London.

Nanopath is a bi-tech startup.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.

Size matters, or rather the uniformity of microparticles makes a big difference. A difference, for example, that can allow an eye surgery to become a outpatient event. MicroSpray technologies are making this a reality by decreasing the size of the drugs into uniform microspheres, which you can then inject into the eye with the smallest gauge needle rather than a more invasive tool. Currently, biopharmaceutical industries use costly chemical methods to manufacture microspheres, which rely on batch-type processes, have a low throughput and produce non-uniform particles. MicroSpray Technologies is developing a spray-manufacturing system which enables reproducible, tight and uniform control of particle size. Allowing clinicians to administer control over the rate at which drugs are delivered to patients, using novel slow release particle technologies.

Biomathematica is a biotech start-up providing a high level modeling service to characterize and understand a biological process, simulate, monitor, control, optimize and modify its behavior. Biomathematica has developed innovative genome-scale metabolic models to answer your questions and improve your business: from genome to microbiome, from genome to cell interactions.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

Nordetect is a biochemical analytics company based in Copenhagen, Denmark, that specializes in the development of Lab-on-a-chip devices for environmental analysis, particularly in the field of agriculture. The company has created a microfluidic chip that accurately detects and quantifies essential macronutrients, including nitrogen, phosphorus, and potassium, in soil. This technology enables reliable and affordable nutrient testing, allowing agronomists and farm-service providers to offer farmers precise insights into their soil's nutritional content. By analyzing the effectiveness of chemical and organic fertilizers, Nordetect's solutions help optimize crop performance and provide recommendations for altering agricultural practices. Founded in 2016, Nordetect aims to enhance the sustainability and efficiency of farming through innovative biochemical analysis.

Biomimetic Solutions develops clean meat tissue engineering technology, and a three dimensional (3D) matrices for cell culture which optimizes the process and makes the process of cell development more suitable. Additionally, it develops scaffolds for regenerative medicine field, toxicological in-vitro tests, and pharmaceutical industry for clinical tests. The company was founded in 2016 and is based in Nova Lima, Brazil.

VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.

Nordetect is a biochemical analytics company based in Copenhagen, Denmark, that specializes in the development of Lab-on-a-chip devices for environmental analysis, particularly in the field of agriculture. The company has created a microfluidic chip that accurately detects and quantifies essential macronutrients, including nitrogen, phosphorus, and potassium, in soil. This technology enables reliable and affordable nutrient testing, allowing agronomists and farm-service providers to offer farmers precise insights into their soil's nutritional content. By analyzing the effectiveness of chemical and organic fertilizers, Nordetect's solutions help optimize crop performance and provide recommendations for altering agricultural practices. Founded in 2016, Nordetect aims to enhance the sustainability and efficiency of farming through innovative biochemical analysis.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Nonfood, operating under the name Aqua Forma, is a California-based corporation founded in 2016. The company specializes in the production of algae-based nutritional food products, emphasizing sustainability and innovation. By utilizing algae, Nonfood aims to create foods that significantly lower the environmental impact associated with traditional agriculture, thereby reducing both resource consumption and carbon emissions. The company focuses on offering convenient and nutritious food options that appeal to consumers seeking healthier alternatives.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Galactica Biotech Limited, founded in 2017 and based in Cork, Ireland, specializes in developing artificial intelligence-based solutions for drug design, machine learning, and systems biology. The company focuses on drug repurposing, utilizing its technology to identify new applications for existing molecules in both market and development phases. This innovative approach aims to discover treatments for major and orphan diseases, thereby reducing risks for patients and minimizing time and costs for pharmaceutical companies.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

Digi.Bio is a company based in Amsterdam, Netherlands, that develops a microfluidic platform aimed at automating liquid handling processes in the healthcare industry. Established in 2017, the firm specializes in digital microfluidics and electrowetting technology, which allows for the precise manipulation of droplets at a microscale. By utilizing artificial intelligence, Digi.Bio's software streamlines multistep liquid handling applications, thereby replacing traditional pipetting methods in laboratories. This innovative approach enhances the efficiency of synthetic biology research and supports medical and pharmaceutical companies in automating their workflows, ultimately facilitating the scaling of bioengineering processes.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Biomimetic Solutions develops clean meat tissue engineering technology, and a three dimensional (3D) matrices for cell culture which optimizes the process and makes the process of cell development more suitable. Additionally, it develops scaffolds for regenerative medicine field, toxicological in-vitro tests, and pharmaceutical industry for clinical tests. The company was founded in 2016 and is based in Nova Lima, Brazil.

ViaeX Technologies Inc. develops and manufactures bio-engineered nano-membrane technology solutions to purify water and air. The company offers its technology solutions for water filtration, air purification, composition control, and other applications. It serves municipalities, governments, industries, and companies worldwide. The company is based in San Francisco, California.

Vali Nanomedical Corporation, a biotechnology company, develops a multidrug-delivery platform technology using proprietary nanoparticles that have multilayered structures. It offers cross-linked multilamellar liposome nanoparticle technology that allows a nano-delivery of multiple chemical payloads in defined ratios to tumors. The company was founded in 2013 and is based in Los Angeles, California.

ViaeX Technologies Inc. develops and manufactures bio-engineered nano-membrane technology solutions to purify water and air. The company offers its technology solutions for water filtration, air purification, composition control, and other applications. It serves municipalities, governments, industries, and companies worldwide. The company is based in San Francisco, California.

BlueTurtleBio Technologies creates a next generation therapeutic using a patent pending platform technology. The company's mission is the golden triangle of healthcare: safety, effectiveness and affordability. Most healthcare options miss one or more of these standards. At Blue Turtle, they plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

Spira is a company focused on producing algae-based ingredients that aim to replace petroleum and animal-derived compounds, promoting sustainability. By utilizing cyanobacteria, Spira develops industrial ingredients that serve various sectors, including beverages, cosmetics, textiles, and confectionery. The company collaborates with a global network of farming partners to manufacture raw materials that not only reduce reliance on petrochemicals but also support carbon capture and wastewater management efforts. Additionally, Spira's initiatives assist farmers in developing countries, contributing to a transition towards healthier materials and more sustainable practices across industries.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.

Our electrospinning process, dubbed Field Guided Fabrication, makes it possible to create 3D fabrics. A close analog to 3D printing, our manufacturing method enables lightweight, seamless fabrics to be created at the touch of a button. Electroloom's Field Guided Fabrication is a platform technology capable creating articles of clothing, tissue engineering scaffolds, filters, and much more.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

Ardra is a startup based on technology developed at the University of Toronto. Their technology uses model-guided metabolic engineering and synthetic biology to develop biocatalysts for the production of specialty chemicals from renewable resources. Their current target is the cosmetics industry, which uses $2.6 billion worth of petroleum chemicals in a variety of products.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

Vali Nanomedical Corporation, a biotechnology company, develops a multidrug-delivery platform technology using proprietary nanoparticles that have multilayered structures. It offers cross-linked multilamellar liposome nanoparticle technology that allows a nano-delivery of multiple chemical payloads in defined ratios to tumors. The company was founded in 2013 and is based in Los Angeles, California.

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

BlueTurtleBio Technologies creates a next generation therapeutic using a patent pending platform technology. The company's mission is the golden triangle of healthcare: safety, effectiveness and affordability. Most healthcare options miss one or more of these standards. At Blue Turtle, they plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome.

Bioloom manufactures bioengineered textiles that replace cotton. The company is based in San Francisco, California.

Our electrospinning process, dubbed Field Guided Fabrication, makes it possible to create 3D fabrics. A close analog to 3D printing, our manufacturing method enables lightweight, seamless fabrics to be created at the touch of a button. Electroloom's Field Guided Fabrication is a platform technology capable creating articles of clothing, tissue engineering scaffolds, filters, and much more.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

Benthic Labs is a synthetic biology company focusing on the synthesis of a new biopolymer using natural filaments. Their project involves the production of a new polymer using filaments made naturally by the Hagfish. These filaments are 100x thinner than a human hair and stronger than nylon, steel and even Kevlar. As the hagfish cannot be farmed economically, they propose synthesising the filament using bacteria to create a new biological material. This material will be lightweight, strong and as it is natural, will be completely biodegradable. What will their new biopolymer be used for? With demand for such a product in the military, medical and automobile sectors, the possibilities are endless!

Verdex Technologies Inc. specializes in designing, patenting, and licensing non-toxic nanofiber production equipment for filtration and biomedical applications. The company’s innovative technology allows for the functionalization of nanofibers by incorporating nano-sized ingredients, which enhances the effectiveness of various products, including water filters that can eliminate challenging contaminants. Based in North Chesterfield, Virginia, Verdex Technologies emphasizes the use of biodegradable and bioresorbable polymers, avoiding harmful solvents and petroleum products in its processes. Founded by Rex B. Kirby, Jr., the company prides itself on its agile structure, integrity, and exceptional service, focusing on client needs and safety while maintaining high standards of quality. Verdex Technologies is financially robust, with substantial bonding capacity, positioning itself as a reliable partner in the nanofiber technology sector.

SouthWest NanoTechnologies was founded in 2001 to commercialize a groundbreaking technology (CoMoCAT®), developed by Professor Daniel Resasco from the University of Oklahoma, for synthesizing single-wall carbon nanotubes (CNTs) with controlled optoelectronic properties. Since then, we've expanded our operations to become the world's leading supplier of high-purity single-wall, few-wall, and multi-wall carbon nanotubes, serving the needs of over 1,000 materials developers worldwide in industries ranging from consumer electronics to energy storage and composite manufacturing. SouthWest NanoTechnologies (SWeNT) produces carbon nanotubes using the patented CoMoCAT® catalytic method in fluidized bed reactors. This results in selective synthesis of single-wall carbon nanotubes and remarkable control of diameter, chirality and purity.